Search Results 41-50 of 17263 for metabolic peptides
Learn about education opportunities available to trainees in Mayo Clinic's Epigenomics of Metabolic Diseases Lab led by Zong Wei, Ph.D.
Through his Metabolic Basis for Type 2 Diabetes and Aging Research Lab at Mayo Clinic, Dr. Nair works with other researchers investigating metabolism, ...
Under Dr. Nair's leadership, the Metabolic Basis for Type 2 Diabetes and Aging Research Lab at Mayo Clinic has four main research projects related to type 2 ...
Research in Dr. Lanza's lab at Mayo Clinic includes adaptive response to exercise, chronic inflammation, mitochondrial physiology, omega-3 fatty acids and ...
Dr. Lanza's lab at Mayo Clinic seeks to maximize the health benefits of exercise by studying muscle physiology, metabolism and chronic disease.
A dual incretin agonist ( GLP-1 /glucose-dependent insulinotropic peptide) tirzepatide also is efficacious in treating obesity, improving glycemic control and ...
... metabolic and cardiovascular benefit or risk as evidenced by beneficial metabolic phenotype (higher GLP-1, secondarily: improved glucose, insulin dynamics).
The purpose of this study is to gather information on the safety and effectiveness of cardiac resynchronization therapy (CRT) in patients who have mild heart ...
The imaging biomarkers will cover an array of methods that could be applicable to non-alcoholic fatty liver disease (NAFLD), including liver fat, liver ...
The purpose of this study is to identify differences in body composition of infants up to 6 months of age according to maternal metabolic status.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!